Sweet, l will be waiting in the DARK SHADOWS for all the cheapies....bring it shorters... but but but yall covered several months ago....thanks by the way...strengthened my position at that time....
This will get Elite Cash Low Positive in 1st Quarter 2020
ER CNS stimulant Undisclosed Filed and under review by FDA ———$1.6 Billion market——— Only——3——“authorized “ generics which pay royalties to the branded Passed alcohol dumping trial Competition are “authorized” generics so Elite will have better cost structure ———PDUFA date December 2019 ——— Launch gets Elite Cash Flow Positive Feb-Mar 2020 Stops further dilution Finances all R&D Removes going concerns Pays for SequestOx trials Pays for filling SunGen#5 with $1.5 Billion Market Massive organic growth DollarLand !
Quote Nasrat: “The last SunGen that was filed in May was an extended-release CNS stimulant that we co-developed with our partner SunGen. The branded and generic sales of this product are approximately $1.6 BILLION and there are currently just FOUR meanufacturers which includes the branded and its authorized generics.“